Coeliac Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old.
- For the healthy/control group: You have never been told by a doctor that you have Celiac Disease, Ulcerative Colitis, Crohn's disease, Irritable Bowel Syndrome (IBS), Functional Dyspepsia, or Type 2 Diabetes.
- For the disease group: You have been diagnosed by a doctor, nutritionist, or naturopath with Celiac Disease, Ulcerative Colitis, Crohn's disease, IBS, Functional Dyspepsia, or Type 2 Diabetes, and you are willing to share paperwork confirming this or speak with the study lead.
- You are able to understand the study and agree to take part in it.
- You are able and willing to follow the study schedule, complete required tasks, and fill out questionnaires.
- You are not planning to change your diet or medical treatments during the study.
Who may not be able to join:
- You have a condition that, in the opinion of the study investigator, could block or narrow your digestive tract in a way that might prevent a swallowed capsule from passing through safely — for example, difficulty swallowing (achalasia), a type of esophageal inflammation, a cancer diagnosis or treatment in the past year, or previous surgery on your esophagus, stomach, small intestine, or colon (confirm with trial site); removal of the appendix or gallbladder more than 3 months ago is generally acceptable.
- You have had symptoms of a blockage in your digestive tract in the 3 months before joining the study.
- You have taken certain medications in the past week that could significantly affect how your gut moves — such as opioid painkillers, anticholinergics, or GLP-1 medications (a type of diabetes/weight drug) — confirm with the trial site which specific medications apply to you.
- You use certain types of laxatives (such as polyethylene glycol, milk of magnesia, lactulose, or stool softeners like docusate, or gut-stimulating prescription drugs like linaclotide or tenapanor) within 7 days of taking the study capsule.
- You have difficulty swallowing or a swallowing disorder that could cause you to inhale the capsule into your lungs.
- You have a known physical abnormality in your digestive tract, such as a narrowing (stricture) or abnormal tunnel (fistula), that causes a blockage.
- You have previously had radiation treatment to your abdomen.
- You are currently pregnant or breastfeeding (if an X-ray is needed to check the capsule has passed, a urine pregnancy test will be done first).
- You have taken antibiotics or done a colon cleanse/bowel prep in the past 2 weeks.
- For the healthy/control group only: You have fewer than 2 bowel movements per week.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chris Andrews, MD, Nimble Science Ltd.
Phone: 8664934633
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation of bacterial composition with gastrointestinal disease states as assessed by PLS-DA mapping.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.